COMMUNIQUÉS West-GlobeNewswire

Vericel to Present at the BIO CEO & Investor Conference
05/02/2018
CAMBRIDGE, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma
05/02/2018
EXTON, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Bio-Path Holdings Appoints Paul Aubert to its Board of Directors
05/02/2018
HOUSTON, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting
05/02/2018
ROCKVILLE, Md., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]
David Taing, MD, DC, CAQSM is Elected to the American Health Council’s Board of Physicians
05/02/2018
NEW YORK, Feb. 05, 2018 (GLOBE NEWSWIRE) -- The American Health Council has elected David Taing, MD, DC, CAQSM, to its Board of Physicians. He is currently a Hospital-Employed Physician and Medical Director of two [...]
Pain Therapeutics Reports 2017 Financial Results and Corporate Update
05/02/2018
– 2018 Focus will be on REMOXY, Fiscal Discipline and Advancing Pipeline – AUSTIN, Texas, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) today reported financial results for the year ended [...]
Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations
05/02/2018
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]
Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Monoclonal Antibody in South Korea
05/02/2018
SEOUL, South Korea and SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Effective February 5th, 2018, Yuhan Corporation (KRX:000100.KS) (Yuhan) and Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) (Sorrento) announce that the [...]
PositiveID’s Chief Science Officer Discusses Company’s Detection of Flu Virus on its FireflyDX Prototype in Interview with CEOLIVE.TV
05/02/2018
DELRAY BEACH, Fla., Feb. 05, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, and its ExcitePCR subsidiary announced today that [...]
Radient Technologies Inc. Announces Approval and Receipt of Controlled Drugs and Substances Licence from Health Canada
05/02/2018
EDMONTON, Alberta, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX-V: RTI ) is pleased to announce that its application for the Controlled Drugs and Substances Licence has [...]
RavenQuest Asked to Be a Primary Resource for Assembly of First Nations in Saskatchewan
05/02/2018
VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is proud to announce that it will be working with First Nation communities from across [...]
AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme® (ferumoxytol injection)
05/02/2018
WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label [...]
ATW Tech Octroie de Nouvelles Options D’achat D’actions
05/02/2018
MONTREAL, 05 févr. 2018 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo Inc. » ou la « Société ») (TSX-V: ATW ) annonce qu’aux termes de son régime d’options d’achat d’actions (le « régime »), un total de 2 387 000 options d’ [...]
Appointment of Chairman
05/02/2018
MELBOURNE, Australia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”, “GTG”), is pleased to announce that the Board of Directors has appointed Dr Paul A. Kasian as [...]
Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference
05/02/2018
Press Release 5 February 2018 Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference Immunicum AB (publ; IMMU.ST) a biopharmaceutical company [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
05/02/2018
REGULATED INFORMATION GHENT, Belgium, 5 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
05/02/2018
REGULATED INFORMATION GHENT, Belgium, 5 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Addex Provides Key Financial Indicators and Trading Update
05/02/2018
Cash position of CHF6.5 million as of 31 January 2018 Geneva, Switzerland, 5 February 2018 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, [...]
Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.
03/02/2018
CONCORD, Ontario, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc. (“ Aspri ), a pharmaceutical products wholesale and manufacturer corporation, announces that on February 1, 2018, Devonian Health Group Inc [...]

Pages